Keros Therapeutics, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
KROS on Nasdaq
Industry
Pharmaceutical Preparations
Location
1050 Waltham Street, Suite 302, Lexington, MA

Insiders trading volume in the past year

Keros Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jasbir Seehra CHIEF EXECUTIVE OFFICER, Director $5.69M Sep 3, 2025
Orbimed Advisors Llc Director $5.26M Aug 13, 2024
Jennifer Lachey Chief Scientific Officer $4.31M Jul 15, 2022
Julius Knowles Director $3.45M Jun 4, 2025
Christopher Rovaldi Chief Operating Officer $2.64M Feb 18, 2025
Ran Nussbaum Director, 10%+ Owner $2.24M Jun 4, 2025
Tomer Kariv Director, 10%+ Owner $2.24M Jun 4, 2025
Yung H. Chyung Chief Medical Officer $1.94M Feb 18, 2025
Keith Regnante Chief Financial Officer $1.94M Feb 18, 2025
Carl L. Gordon Director $1.8M Jun 4, 2025
Esther Cho SVP, General Counsel $637K Aug 6, 2025
Lorena Raquel Lerner Chief Science Officer $507K Aug 6, 2025
Pontifax Management 4 G.P. (2015) Ltd. 10%+ Owner $166K -$85M -99.8% Oct 15, 2025
Jean Jacques Bienaime Director $78.7K Jun 4, 2025
Nima Farzan Director $75.8K Jun 4, 2025
Mary Ann Gray Director $75.8K Jun 4, 2025
Alpna Seth Director $75.8K Jun 4, 2025
ADAR1 Capital Management, LLC 10%+ Owner $0 -$86.2M -100% Oct 15, 2025
Claudia Ordonez Chief Medical Officer Jun 11, 2021
Simon Peter Cooper Chief Medical Officer Feb 13, 2024

Recent Insider Transactions by Companies or Individuals for Keros Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.